A best evidence topic in thoracic surgery was written according to a structured protocol. The question addressed was 'in patients with primary lung carcinoma, does the sequence of pulmonary vasculature ligation during anatomical lung resection influence the oncological outcomes?' A total of 48 papers were found using the reported search, of which 7 represented the best evidence to answer the question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Among six prospective studies included, five of them randomized patients to either pulmonary vein or artery occlusion first during anatomical lung resection, while one study was retrospective. Two reports did not find any difference between pulmonary vein and artery occlusion first during long-term follow-up in terms of either disease recurrence (51 vs 53%, P = 0.7), or 5-year overall survival (54 vs 50%, P = 0.82). One report did not find any difference with regard to circulating tumour cells either after thoracotomy (5.0 vs 3.9, P = 0.4), or after the completion of lobectomy (38.0 vs 70.0, P = 0.23). One report found a higher expression of CD44v6 (P = 0.008) and CK19 (P = 0.05) in patients undergoing pulmonary arterial occlusion first. One report found that pulmonary vein occlusion before that of the pulmonary arterial branches has a favourable outcome on circulating carcino-embryonic antigen (CEA) mRNA in the peripheral blood, while another one did not find a significant difference in circulating levels of CEA mRNA (P = 0.075) and CK19 mRNA (P = 0.086) with either method. Another study reported no correlation between circulating pin1 mRNA levels in peripheral blood after the completion of the resection and the sequence of ligation of pulmonary vessels (9.95 ± 0.91 vs 14.71 ± 1.64, P > 0.05). Based on the two studies assessing the long-term outcome of patients with primary lung cancer undergoing anatomical curative resection, the sequence of ligation of pulmonary vessels does not seem to influence the oncological outcomes or survival. However, the other studies focusing on the influence of these techniques on circulating tumour cells or their molecular products report conflicting results the clinical consequences of which cannot be predicted.
INTRODUCTION
A best evidence topic was constructed according to the proposed structured protocol, which is fully described in the ICVTS [1] .
THREE-PART QUESTION
In [ patients undergoing anatomic lung resection for non-small cell lung carcinoma], does [the sequence of pulmonary vasculature occlusion] has any [oncologic impact]?
CLINICAL SCENARIO
A 68-year old male patient has been diagnosed with non-smallcell lung cancer (NSCLC) of the right upper lobe. After the preoperative work-up and a negative distant and mediastinal metastatic staging, you decide that the most appropriate therapeutic approach would be a right upper lobectomy along with mediastinal lymph node dissection. Before surgery, a discussion with your assistant raises the issue whether dissecting and individually ligating the pulmonary artery (PA) branches to the upper lobe before doing so for the upper lobe branch of the superior pulmonary vein (PV) might affect the oncological outcome of the procedure. You resolve to check the literature yourself.
SEARCH STRATEGY
Ovid MEDLINE(R) 1946 to July 2014 was searched using the following search terms: [ 
SEARCH OUTCOME
Forty-eight studies were identified using the reported search criteria and 7 were selected as the best evidence on the topic (Table 1) . 
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RESULTS
Refaely et al. [2] reviewed 279 patients undergoing anatomical lung resection for NSCLC and classified them into two groups: n = 133, PV ligated first (PV) vs n = 149 PA first group (PA). The mean follow-up period was 22.6 months (range: 0.16-106 months); disease recurrence did not differ among the two groups [PV: n = 68 (51%), PA; n = 78 (53%), P = 0.7]. Multivariate analysis did not demonstrate the sequence of vessel interruption affecting disease recurrence (odds ratio = 1.29, 95% confidence interval 0.73-2.29, P = 0.4). Kozak et al. [3] prospectively randomized 385 patients undergoing lobectomy for NSCLC into PV first (n = 170) or PA first (n = 215) groups. The mean follow-up duration was 61.5 ± 39.5 months. There were no differences in either the 5-year overall survival (PV 54 vs PA 50%, P = 0.82), or in the incidence of haematogenous metastases during the follow-up period (PV 14.7% vs PA 20.5%, P = 0.18).
Hashimoto et al. [4] studied the effect of surgical manipulation of the tumour-bearing lobe on the spillage of tumour cells. The authors performed a non-randomized study where 30 patients undergoing lobectomy for NSCLC had PA ligation first (PA group, n = 21) or PV ligation first (PV group, n = 9). There was no difference in tumour cell spillage in the blood after thoracotomy and before the resection (PA group 3.9 vs PV group 5.0, P = 0.4) and after the completion of the lobectomy (PA group 70.0 vs PV group 38.0, P = 0.23).
Song et al. [5] randomized 30 patients undergoing lobectomy for NSCLC in either PA ligation first (n = 15), or PV ligation first (n = 15). The authors studied the expression of CD44v6 and CK19 from blood samples retrieved from the proximal part of the PV immediately after thoracotomy and before its dissection. Patients undergoing PA ligation first had significantly increased levels of CD44v6 (P = 0.008) and CK19 (P = 0.05) at the conclusion of the lobectomy (when the draining vein was cut-off ), while those undergoing PV ligation first did not have any difference (P = 0.558 and P = 0.532, respectively).
Kurusu et al. [6] randomized 30 patients who had lobectomy for NSCLC into two groups depending on whether the PV (n = 15) or artery (n = 15) was ligated first. Carcinoembryonic antigen messenger RNA (CEA mRNA) in the peripheral blood before surgery, 16.84 ± 2.36 P >0.05
After operation -PA group: 14.71 ± 1.64 -PV group: 9.95 ± 0.91 P >0.05 circulation, which can be attributed to the decrease in cancer cell spillage NSCLC: non-small-cell lung cancer; SCLC: small-cell lung cancer; PA: pulmonary artery; PV: pulmonary vein; 95% CI: 95% confidence interval; OR: odds ratio.
5 min after first vessel ligation, 5 min after second vessel ligation and after the completion of surgery was measured. CEA mRNA was taken as a marker of neoplastic cells. Of 30 preoperative samples, 16 were CEA mRNA positive; of these 16, 8 remained positive after lobectomy. The remaining 8 (n = 4 in each group) were negative. Of the 14 initially negative samples (n = 7 in each ligation group), 9 became positive during the operation. The conversion during the operation was more common with PA ligation first (n = 6, 85.7%) vs PV ligation (n = 3, 42.9%).
Ge et al. [7] randomized 23 patients undergoing anatomical lung resection for primary lung cancer in either the PA ligation first (PA group, n = 11) or PV ligation first group (PV group, n = 12). The expression of either CK19 mRNA (PA group 5.058 vs PV group 4.503, P = 0.086) or CEA mRNA (PA group 4.817 vs PV group 4.397, P = 0.075) did not differ significantly between these two groups.
Finally, Ai et al. [8] prospectively randomized 26 patients undergoing lobectomy for NSCLC into two groups, namely PV first (n = 14) vs PA first (n = 12). Levels of pin1 mRNA were measured as a surrogate marker of tumour cell dispersion (an isomerase overexpressed in several human cancers in peripheral blood samples. Pin1 mRNA is overexpressed in patients with NSCLC when compared with healthy volunteers and patients with benign lung disease (P < 0.05), and it is increased in patients with stage III disease when compared with patients with Stage I and II disease (18.48 ± 1.64 vs 10.57 ± 1.05, respectively, P < 0.05), as well as in patients with lymph node positive disease when compared with those with lymph node negative disease (18.93 ± 2.10 vs 10.02 ± 1.23, respectively, P < 0.05). Furthermore, pin1 mRNA levels were elevated in the distal PV when compared with the proximal PV (30.56 ± 1.37 vs 20.31 ± 1.48, respectively, P < 0.05). However, there were no significant difference in peripheral blood pin1 mRNA after surgery between patients undergoing either pulmonary vein or artery ligation first (9.95 ± 0.91 vs 14.71 ± 1.64, respectively, P > 0.05).
CLINICAL BOTTOM LINE
Based on the two studies assessing the long-term outcome of patients with primary lung cancer undergoing anatomical curative resection, the sequence of ligation of pulmonary vessels does not seem to influence oncological outcomes or survival. However, the other studies focusing on the influence of these techniques on circulating tumour cells or their molecular products report conflicting results, the clinical consequences of which cannot be predicted.
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